These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8475870)
1. Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems. Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Scheld HH; Borggrefe M; Breithardt G Am J Cardiol; 1993 May; 71(12):1064-8. PubMed ID: 8475870 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
3. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. Pires LA; May LM; Ravi S; Parry JT; Lal VR; Nino CL Am J Cardiol; 2000 Mar; 85(6):725-8. PubMed ID: 12000047 [TBL] [Abstract][Full Text] [Related]
4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy. Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator. Neglia JJ; Krol RB; Giorgberidze I; Mathew P; Lewis C; Munsif AN; Saksena S J Interv Card Electrophysiol; 1997 Feb; 1(1):49-56. PubMed ID: 9869951 [TBL] [Abstract][Full Text] [Related]
7. Implantable transvenous cardioverter-defibrillators. Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144 [TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators. Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group. J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508 [TBL] [Abstract][Full Text] [Related]
10. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. Kleemann T; Strauss M; Kouraki K; Zahn R Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746 [TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699 [TBL] [Abstract][Full Text] [Related]
12. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation]. Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401 [TBL] [Abstract][Full Text] [Related]
13. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573 [TBL] [Abstract][Full Text] [Related]
14. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention. Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248 [TBL] [Abstract][Full Text] [Related]
15. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ; J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332 [TBL] [Abstract][Full Text] [Related]